Juniper Pharma (JNP) Misses Q2 EPS by 1c

Juniper Pharma (NASDAQ: JNP) reported Q2 EPS of ($0.03), $0.01 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $10.2 million versus the consensus estimate of $7.8 million.

For earnings history and earnings-related data on Juniper Pharma (JNP) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Universal Logistics Holdings, Inc. (ULH) Tops Q1 EPS by 136c
• Data I/o Corp (DAIO) Misses Q2 EPS by 7c